Article
Targeting the Wnt signaling pathway in colorectal cancer.
Expert opinion on therapeutic targets - 1 Jan 2016
Sawa Masaaki, Masuda Mari, Yamada Tesshi
Abstract excerpt
INTRODUCTION: The treatment of patients with advanced colorectal cancer still remains challenging, and identification of new target molecules and therapeutic avenues remains a priority. The great majority of colorectal cancers have mutations in one of two genes involved in the Wnt signaling pathway: the adenomatous polyposis coli (APC) and β-catenin (CTNNB1) genes. Up to now, however, no therapeutics for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
